Compartilhar
Informação da revista

Estatísticas

Siga este link para acessar o texto completo do artigo

438
ISATUXIMAB PLUS POMALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: ICARIA-MM SUBGROUP ANALYSIS
M.E.Z. Capraa, M. Beksacb, P.G. Richardsonc, A. Unald, P. Corradinie, S. Delimpasif, Z. Gulbasg, G. Mikalah, A. Neyloni, A. Symeonidisj, S. Bringhenk, P. Moreaul, H.V. Veldem, F. Campanam, S.L. Guennecn, I. Spickao
a Hospital Mãe de Deus, Porto Alegre, RS, Brazil
b Department of Hematology, Ankara University, Ankara, Turkey
c Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States
d Department of Hematology, Erciyes University Medical School, Kayseri, Turkey
e Division of Hematology, Istituto Nazionale dei Tumori, University of Milano, Milan, Italy
f Department of Haematology, General Hospital of Athens, Athens, Greece
g Anadolu Medical Center, Kocaeli, Turkey
h Department of Hematology and Stem Cell Transplantation, South Pest Central Hospital, Budapest, Hungary
i Department of Haematology, Dunedin Hospital, Dunedin, New Zealand
j Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece
k Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy
l Hematology Department, Nantes University Hospital, Nantes, France
m Sanofi R&D, Cambridge, United States
n Sanofi R&D, Vitry-Sur-Seine, France
o 1st Department of Medicine – Department of Hematology First Faculty of Medicine Charles University and General Hospital in Prague, Prague, Czech Republic
Ver más
Lido
2724
Vezes
que se leu este artigo
1287
Total PDF
1437
Total HTML
Compartilhar estatísticas
Informação do artigo
ISSN: 25311379
Idioma original: Inglês
Dados atualizados diariamente
Ano/Mês Html Pdf Total
2025 6 23 6 29
2025 5 50 16 66
2025 4 44 14 58
2025 3 55 14 69
2025 2 36 21 57
2025 1 39 28 67
2024 12 29 13 42
2024 11 41 20 61
2024 10 30 18 48
2024 9 24 22 46
2024 8 30 24 54
2024 7 22 21 43
2024 6 28 26 54
2024 5 27 26 53
2024 4 30 22 52
2024 3 23 23 46
2024 2 15 24 39
2024 1 16 19 35
2023 12 16 23 39
2023 11 35 36 71
2023 10 17 31 48
2023 9 22 27 49
2023 8 13 17 30
2023 7 23 17 40
2023 6 35 16 51
2023 5 26 15 41
2023 4 25 14 39
2023 3 39 12 51
2023 2 29 9 38
2023 1 13 12 25
2022 12 30 22 52
2022 11 22 15 37
2022 10 23 23 46
2022 9 30 29 59
2022 8 30 28 58
2022 7 15 24 39
2022 6 19 25 44
2022 5 13 20 33
2022 4 14 27 41
2022 3 12 34 46
2022 2 15 23 38
2021 1 15 34 49
2021 12 16 25 41
2021 11 22 29 51
2021 10 22 47 69
2021 9 34 44 78
2021 8 22 32 54
2021 7 26 32 58
2021 6 20 22 42
2021 5 18 35 53
2021 4 53 36 89
2021 3 33 25 58
2021 2 22 23 45
2020 1 17 18 35
2020 12 15 14 29
2020 11 24 15 39
Mostrar tudo

Siga este link para acessar o texto completo do artigo

Idiomas
Hematology, Transfusion and Cell Therapy